#United States #Miami #Cancer Research #Baptist Health #START Center

Strategic Partnership for Cancer Research

Baptist Health South Florida has teamed up with The START Center for Cancer Research, marking a significant advancement in cancer treatment accessibility in the region. This collaboration aims to establish a new site for early-phase clinical trials in conjunction with the Herbert Wertheim Cancer Institute, making it easier for local patients to access groundbreaking cancer therapies that are currently under investigation.

Addressing a Critical Need

In Florida, over 130,000 new cancer diagnoses occur every year, and many patients have found it challenging to access early-phase clinical trials due to their geographical location. Historically, patients were often required to travel long distances to eligible facilities for participation in such vital research. The partnership between Baptist Health and START is set to bridge this gap, offering localized opportunities for patients in a community that needs it.

Collaborative Expertise

START brings years of specialized experience in conducting early-phase oncology trials, while Baptist Health provides a robust network of esteemed cancer specialists, centered around the Herbert Wertheim Cancer Institute and Lynn Cancer Institute. This strategic union promises to enhance patient care by offering cutting-edge investigational therapies right where patients have been receiving their treatment.

Nick Slack, MBE, the Chairman and CEO of START, emphasized the significance of this partnership by stating, "START's mission is to bring the hope of early-phase clinical trials to every community." He further noted that millions living in South Florida deserve world-class cancer research opportunities without the need to travel far from their homes. The collaboration aims to serve cancer patients in community settings where they feel more comfortable accessing treatments that could be life-changing.

Simplifying Access for Patients

Dr. Leonard Kalman, acting system chief executive of Baptist Health Cancer Care, echoed the importance of this partnership. He commented that the collaboration with START would allow local patients and their physicians to easily access pioneering oncology trials, reducing the need to travel hundreds of miles for potentially life-saving research. This streamlined approach to clinical trials is particularly significant for a large and diverse community like South Florida.

A Broader Reach

Baptist Health is recognized as the largest not-for-profit healthcare organization in the region, maintaining a comprehensive infrastructure that includes 12 hospitals, over 29,000 employees, and countless outpatient facilities. START is known for operating a global network dedicated to early-phase clinical trials, with more than 40 principal investigators and an extensive portfolio of almost 1,000 active studies.

The collaboration will integrate the new site into START’s existing network, granting immediate access to a wealth of ongoing investigations and treatments. This means patients at Baptist Health will no longer be limited to standard treatments but can explore advanced options seamlessly.

Looking Ahead

With this landmark partnership set in motion, the future of cancer treatment in South Florida looks promising. It not only raises hopes for better access to cutting-edge therapies but also reflects a significant advancement in community-based healthcare. As both organizations move forward with their shared mission, the ultimate aim remains focused on improving cancer treatment outcomes and meeting the urgent needs of patients battling this disease.

For more information on this initiative, visit START Center for Cancer Research and Baptist Health South Florida.